Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Health Psychol. 2017 Aug 21;36(11):1047–1058. doi: 10.1037/hea0000540

Resilience and Biomarkers of Health Risk in Black Smokers and Nonsmokers

Carla J Berg 1, Regine Haardörfer 1, Colleen M McBride 1, Varun Kilaru 2, Kerry J Ressler 3,4,5, Aliza P Wingo 3,4, Nabil F Saba 6, Jackelyn B Payne 1, Alicia Smith 2,3
PMCID: PMC5653434  NIHMSID: NIHMS900252  PMID: 28825494

Abstract

Objectives

Blacks are disproportionately affected by tobacco-related illnesses as well as traumatic events that are associated with psychiatric conditions and smoking. We examined the potential protective nature of resilience within this context, hypothesizing that resilience differentially moderates the associations of traumatic experiences to depressive symptoms as well as to biomarkers of health risk among Black ever versus never smokers.

Methods

Measures of resilience, traumatic experiences, depressive symptoms, and biomarkers (interleukin-6 [IL-6], C-reactive protein [CRP], allostatic load) were obtained among 852 Blacks recruited from Grady Memorial Hospital in Atlanta to participate in a study of trauma.

Results

Ever smokers experienced more trauma (p’s<.001) and depressive symptoms (p=.01). Structural equation modeling indicated that, in ever smokers, childhood trauma was positively associated with depressive symptoms (p<.001); resilience was negatively associated with depressive symptoms (p=.01). Depressive symptoms were positively associated with IL-6 (p=.03), which was positively associated with allostatic load (p=.01). Adulthood trauma was associated with higher CRP levels (p=.03). In never smokers, childhood (p<.001) and adulthood trauma (p=.01) were associated with more depressive symptoms. Adulthood trauma was also associated with higher CRP levels (p<.001), which was positively associated with allostatic load (p<.001). Never smokers with higher resilience had a negative association between childhood trauma and depressive symptoms, whereas those with lower resilience had a positive association between childhood trauma and depressive symptoms. Resilience was negatively associated with CRP levels (p<.001).

Conclusions

Interventions targeting resilience may prevent smoking and adverse health outcomes as well as provide a basis for understanding mechanisms of intervention impact.

Keywords: Tobacco use, Health disparities, Trauma, Depression, Resilience

INTRODUCTION

Health is impacted by social environment, health behaviors, and endogenous biological responses that occur across the lifespan, a complement that is increasingly referred to as the exposome (Miller & Jones, 2014). The exposome comprises overlapping domains that include: 1) general external environments (e.g., urbanicity, social capital, interpersonal relationships); 2) specific external environments (e.g., dietary habits, tobacco use); and 3) internal biological environments (e.g., metabolic factors, inflammation, oxidative stress; Miller & Jones, 2014). These environmental domains interact with each other to effect health outcomes (Miller & Jones, 2014; Wild, 2012). The public health exposome model conceptualizes these pathways to include environmental exposures, personal characteristics, and moderating factors, that in turn, are associated with health disparities among communities at greatest risk (Juarez, 2013). One such community is Blacks in the US. Indeed, it is this chronicity of lifetime exposures that Geronimus and colleagues posited in their “weathering hypothesis”: Blacks show higher cumulative risk measurements than Whites, and these differences are not explained by poverty alone (Geronimus, Bound, Waidmann, Hillemeier, & Burns, 1996; Geronimus, Hicken, Keene, & Bound, 2006). This hypothesis provides a framework for examining the impact of exposure factors with greater prevalence among Blacks that may together influence health outcomes.

An important exposure associated with multiple negative health outcomes is the experience of traumatic events (e.g., experiencing, witnessing, or being confronted with death, serious injury, or physical threat to self or others (American Psychological Association [APA], 1994)), particularly those that occur in childhood. Such trauma has been associated with the development of substance abuse and dependence, including cigarette smoking (Hovdestad, Campeau, Potter, & Tonmyr, 2015; Simpson & Miller, 2002), as well as mental health problems (e.g., depression, anxiety, suicidality; Enns et al., 2006; Gilbert et al., 2009; Kessler, Davis, & Kendler, 1997; MacMillan et al., 2001; Scott, Smith, & Ellis, 2010), interpersonal difficulties (Jaffee & Gallop, 2007; Wolfe, Scott, Wekerle, & Pittman, 2001), compromised academic and occupational functioning (Cicchetti & Rogosch, 1997; Gilbert et al., 2009), aggression, violence, and criminal behaviors (Casiano, Mota, Afifi, Enns, & Sareen, 2009; Gilbert et al., 2009; Ou & Reynolds, 2010). Cumulatively, the impact of traumatic experiences on health are significant and multidimensional. Blacks are disproportionately exposed to traumatic events of various types (Breslau, Davis, & Andreski, 1995; Green, Grace, Lindy, & Leonard, 1990). Compared to Whites, Blacks are more likely to report higher rates of childhood trauma, including parental death and severe alcoholism, as well as extreme economic deprivation (Breslau et al., 1995; Green et al., 1990). Blacks experience more traumatic events in adulthood, such as being attacked or raped, threatened with a weapon, or witnessing an injury or murder (Breslau et al., 1995). Blacks also have higher lifetime and current rates of posttraumatic stress disorder (Breslau et al., 1995; Green et al., 1990).

Blacks are disproportionately affected by tobacco-related illnesses. Each year, approximately 45,000 Blacks die from smoking-related disease (American Cancer Society [ACS], 2011; Centers for Disease Control and Prevention [CDC], 1998). Smoking-related illnesses are the number one cause of death in the Black community, surpassing all other causes of death, including AIDS, homicide, diabetes, and accidents (ACS, 2011). Blacks suffer disproportionate tobacco-related morbidity and mortality despite the fact that they tend to smoke fewer cigarettes per day and begin smoking later in life (Alexander et al., 2016). This phenomenon remains unexplained but has been attributed to a variety of factors including stress associated with living in conditions of socio-environmental disadvantage. Additionally, Blacks are less likely to quit smoking than Whites, resulting in sustained exposure to tobacco smoke for a longer period of their life (Holford, Levy, & Meza, 2016).

The disproportionate burden of smoking-related diseases among Blacks is further compounded by the co-occurrence of smoking and depression that can result from trauma. Studies have shown an increased risk of nicotine dependence among individuals who report exposure to trauma or adverse events (Al Mamun et al., 2007; Breslau, Davis, & Schultz, 2003; Hapke et al., 2005), an association that may be particularly unique to smoking. For example, Breslau and colleagues (Breslau et al., 2003) found an association between trauma exposure and 10-year cumulative incidence of nicotine dependence but no association between trauma exposure and alcohol use. Depressive symptoms also commonly co-occur among those who have been exposed to a traumatic life event (Fergusson, Horwood, & Lynskey, 1996; O'Donnell, Creamer, & Pattison, 2004). Depressive symptoms are strongly associated with nicotine dependence (Breslau et al., 1998; Fergusson et al., 1996; M. Windle & Windle, 2001).

Resilience is a personal characteristic that may account for differential health outcomes among people with histories of trauma. Definitions of resilience have included: positive outcomes despite serious threats to adaptation and development (Masten, 2001); the absence of a particular negative outcome in at-risk populations (e.g., absence of psychiatric disorder or suicidality) (Collishaw et al., 2007); or a composite score based on indices of functioning reflecting both positive outcomes (e.g., educational attainment, employment history) and a lack of negative outcomes (e.g., homelessness, substance use) (McGloin & Widom, 2001). The Connor-Davidson Resilience Scale (CD-RISC) is a comprehensive assessment of personal strengths that contribute to positive outcomes among individuals faced with adversity. The CD-RISC is one of few multi-dimensional measures available for use with adults and includes: personal competence, perseverance, tolerance of negative affect, acceptance of change, sense of social support, trust in one's instincts, spiritual faith, and an action-oriented approach to solving problems (Campbell-Sills & Stein, 2007; Connor & Davidson, 2003). Prior research has found that this measure of resilience may buffer the effects of traumatic experiences on mental health and cigarette smoking (Campbell-Sills & Stein, 2007; Goldstein, Faulkner, & Wekerle, 2013). However, no previous research has examined the differential role of resilience on depressive symptoms and smoking among Blacks, which is particularly relevant given the range of sociodemographic and psychosocial differences between smokers and nonsmokers (e.g., educational attainment, income levels, age) (Agaku, King, Dube, CDC, 2014; Agaku, King, Husten, et al., 2014).

Additionally, while resilience has frequently been examined in terms of mental health outcomes, it has been infrequently examined in relation to the internal environmental component of the exposome, such as physiological biomarkers associated with illness or disease (e.g., cancer risk). Such biomarkers might include interleukin-6 (IL-6), C-reactive protein (CRP), and allostatic load. IL-6 is an interleukin that acts as both a pro-inflammatory and anti-inflammatory cytokine (Ferguson-Smith et al., 1988). It is secreted by T cells and macrophages to stimulate immune response (e.g. during infection and after trauma) and has been found to be associated with several types of chronic diseases including cardiovascular disease and cancer as well as increased mortality (Volpato et al., 2001). CRP is a sensitive marker of systemic low-grade inflammation and is currently recommended as the principal inflammatory marker in research and clinical practice (Pearson et al., 2003). Elevated plasma levels of CRP have been associated with an increased risk of coronary heart disease (Koenig et al., 1999; Ridker, Rifai, Rose, Buring, & Cook, 2002), ischemic stroke (Rost et al., 2001), peripheral artery disease (Ridker, Cushman, Stampfer, Tracy, & Hennekens, 1998), hypertension (Sesso et al., 2003), and any cardiovascular disease (Ridker, Buring, Cook, & Rifai, 2003; Ridker et al., 2002) in individuals who have no prior cardiovascular disease. CRP has also found to predict the risk of recurrent myocardial infarction (Ridker, 1998) and mortality (Lindahl, Toss, Siegbahn, Venge, & Wallentin, 2000) in patients with coronary heart disease and is also associated with cancer risk (Chaturvedi et al., 2010; Trichopoulos, Psaltopoulou, Orfanos, Trichopoulou, & Boffetta, 2006). Moreover, elevated plasma CRP levels have been associated with obesity, insulin resistance, the metabolic syndrome, endothelial dysfunction, and an increased risk of developing Type 2 diabetes (Festa et al., 2000; Freeman et al., 2002; Ridker et al., 2003; Yudkin, Stehouwer, Emeis, & Coppack, 1999). Allostatic load is one biomarker that captures the “weathering” the body experiences as it strives to achieve stability in disruptive environments, and elevated IL-6 and CRP levels may be precursors to increased allostatic load (McEwen, 1998). Allostatic load is commonly conceptualized as an aggregate measure of disease risk markers, such as blood pressure, body mass index (BMI), waist circumference, and blood glucose (Barboza Solis et al., 2015; Seeman, Singer, Rowe, Horwitz, & McEwen, 1997). Having a history of smoking has been associated with IL-6 (Bermudez, Rifai, Buring, Manson, & Ridker, 2002), CRP (Ohsawa et al., 2005), and allostatic load (McEwen, 1998), and thus, those with a history of smoking should be examined separately from those without such a history in terms of other environmental exposures related to these outcomes.

Consistent with the weathering framework, we examined whether the association of exposure to traumatic experiences’ with depressive symptoms, and in turn, allostatic load would be moderated by resilience in a heterogeneous cohort of black adults (see Figure 1). Additionally, we hypothesized that these associations may differ for smokers and nonsmokers. Our assumptions in testing the models were that childhood traumatic experiences pre-date tobacco initiation and ongoing use as well as depressive symptoms. However, the availability of additional measures of adult exposure to traumatic experiences provides a lifetime exposome indicator that has not been available in other studies. Given consistent evidence of positive associations between smoking and trauma exposure as well as depression, we hypothesized that their joint influences on weathering might differ for smokers and nonsmokers. We tested structural equation models to capture the complexity of the potential associations among these factors. Such approaches are essential for sorting out the complex and interdependent factors that are likely to contribute to health disparities. Characterizing groups for whom the link between depression and resilience is most pronounced could inform future interventions for tobacco users.

Figure 1.

Figure 1

Conceptual framework examining exposures across the exposome and impact on health risk biomarkers

METHODS

Participants & Procedures

This analysis was part of a larger study investigating genetic and trauma-related risk factors for post-traumatic stress disorder and depression in a population of urban, low-income, highly traumatized, predominantly Black men and women (Binder et al., 2008; Bradley et al., 2008). Inclusion criteria included ages 18 to 75 years, understanding English, and ability to give informed consent. The study was approved by the Emory University Institutional Review Board.

Members of the research team approached adult patients waiting for their outpatient appointments at the primary medical care or obstetrical-gynecological clinics of Grady Memorial Hospital in Atlanta, Georgia, to solicit for study participation (Binder et al., 2008; Bradley et al., 2008). If the first participant that the staff approached in the waiting room did not agree to do the study, the staff approached at least two additional possible participants. Of those approached first by staff, 58% agreed, and a cumulative percentage of 84% and 91% of the second and third participants approached agreed if the initial participant approached did not participate. Participants gave informed consent and completed a battery of self-report measures. Due to variation between participants with respect to literacy, all self-report measures were obtained by interview. Blood pressure, weight (kg), height (cm), and waist circumference (cm) were obtained by trained nursing staff at the Grady Hospital Clinical Research Center. Current analyses focused on all Black participants with data available regarding smoking history, traumatic experiences, depression, resilience, and measures of IL-6, CRP, and physiological measures used to calculate allostatic load (n=852).

Measures

Lifetime history of smoking was assessed using responses from the Kreek-McHugh-Schluger-Kellogg (KMSK) scale (Kellogg et al., 2003). Participants were grouped into “never smokers” and “ever smokers” for structural equation modeling.

Covariates & Predictors

Sociodemographics included age, sex, education, income, employment, and disability.

Childhood Trauma Questionnaire (CTQ)

Childhood abuse was assessed retrospectively using the 28-item Childhood Trauma Questionnaire (CTQ) (D. Bernstein & Fink, 1998; D. P. Bernstein et al., 2003). This scale uses a five-point Likert scale, which range from “never true” (scored 1) to “very often true” (scored 5). Reliability for the CTQ is good with high internal consistency scores. Sexual Abuse, Emotional Neglect, Emotional Abuse, and Physical Abuse have reported coefficients of .93–.95, .88–.92, .84–.89, and .81–.86, respectively. Over a three-month period, the test-retest coefficient was 0.80. Factor analysis on the five-factor CTQ model showed structural invariance, demonstrating good validity (D. Bernstein & Fink, 1998; D. P. Bernstein et al., 2003).

Traumatic Events Inventory (TEI)

Adulthood trauma was assessed using the Traumatic Events Inventory (Gillespie et al., 2009; Schwartz, Bradley, Sexton, Sherry, & Ressler, 2005). This instrument screens for lifetime exposure to different categories of trauma, including natural disaster, serious accident or injury, sudden life-threatening illness, military combat, being attacked with a weapon, witnessing a family member or friend being attacked with a weapon, being attacked without a weapon, witnessing a family member or friend being attacked without a weapon, witnessing the murder of a friend or family member, or being sexually assaulted under duress. For each category of the instrument, having had the exposure was scored as 1 and no exposure as 0. Score ranges from 0 to 15 for adulthood trauma, with higher scores reflecting exposure to more types of trauma. The childhood trauma items in this inventory were excluded to avoid overlap with the information collected with the CTQ.

Beck Depression Inventory (BDI)

Depression was measured with the 21-item Beck Depression Inventory (BDI), which has a high degree of reliability and validity (Beck, Ward, Mendelson, Mock, & Erbaugh, 1961). Items were rated on a four-point Likert scale of 0 to 3; total score ranges from 0 to 63, with higher scores reflecting higher levels of depression. Levels of depression severity are suggested by the following score ranges: ≤9 reflects no depressive symptoms, 10 to 18 mild symptoms, and ≥19 moderate to severe depressive symptoms (Beck et al., 1961). This variable was operationalized as a continuous variable.

Moderator

Connor-Davidson Resilience Scale (CD-RISC)

Resilience was assessed with the ten-item Connor-Davidson Resilience Scale (CD-RISC) (Campbell-Sills & Stein, 2007; Connor & Davidson, 2003). Example items include: “can deal with whatever comes” and “think of self as strong person.” The full CD-RISC was found to have an unstable structure across two demographically equivalent samples and was thus modified into a ten-item scale with good internal consistency, construct validity, and excellent psychometric properties for efficient measurement of resilience (Campbell-Sills & Stein, 2007; Connor & Davidson, 2003) (e.g., Cronbach’s alpha=.91 (Gonzalez, Sierra, Martinez, Martinez-Molina, & Ponce, 2015); item separation reliability=.98 (Gonzalez et al., 2015); high content validity (G. Windle, Bennett, & Noyes, 2011)). Items were rated on a five-point Likert scale, ranging from “not true at all” (scored 0) to “true nearly all the time” (scored 4). Scores range from 0 to 40, with higher score reflecting greater resilience.

Biomarker Outcomes

Interleukin-6 (IL-6) and C-Reactive Protein (CRP)

Whole blood was collected under fasting conditions between 8:00 am and 9:00 am and processed by centrifugation to separate the plasma from the buffy coat. Plasma samples were used to assess IL-6 and CRP, as well as cortisol (used in the measure of allostatic load below).

Allostatic Load

Allostatic load was operationalized as an aggregate measure of biomarkers of disease risk. Individual biomarker scores were standardized and summed, creating a cumulative allostatic load score. We adapted our measure from Seeman et al.’s (Seeman et al., 1997) seminal measure of allostatic load to include a culmination of biomarkers known to be linked with various health outcomes. This is a standard way to measure allostatic load in the literature, as sums across physiological systems are better indicators of cumulative dysregulation than individual biomarker scores (Geronimus, Hicken, Keene, & Bound, 2006; Karlamangla, Singer, McEwen, Rowe, & Seeman, 2002; Seeman, McEwen, Rowe, & Singer, 2001; Seeman et al., 1997). This approach has been studied in population-based survey research and indicated that higher allostatic load scores were associated with higher morbidity and mortality (Seeman et al., 2001; Seeman et al., 1997). Moreover, lower allostatic load scores were associated with higher educational levels and better psychosocial factor scores (Seeman et al., 2004; Seeman, Singer, Ryff, & Levy-Storms, 2002).

The five factors comprising the allostatic load measure were: cortisol, systolic blood pressure, diastolic blood pressure, BMI, and waist-to-hip circumference. We selected these biomarkers from available data based on their roles as indicators of disease risk and use in prior allostatic load research (Doamekpor & Dinwiddie, 2015; Mauss, Li, Schmidt, Angerer, & Jarczok, 2015; Seeman et al., 1997; Steptoe et al., 2014; Upchurch et al., 2015). For each factor, the following dichotomizations were made: 1) cortisol ≥16.6 mg/dL, which represents the highest quartile of this cohort; 2) systolic blood pressure ≥140; 3) diastolic blood pressure ≥90 mmHg; 4) BMI ≥30; and 5) abdominal obesity based on a waist circumference of >102 cm for men or >88 cm for women. A point was assigned for each criterion, yielding scores of 0 to 5, with 5 indicating highest risk.

Data Analysis

Descriptive univariate analyses were conducted to assess distributions and the extent of missing data. Bivariate analyses were used to examine the differences between ever smokers and never smokers. These were followed by analyses into the patterns of missing data and multivariable regression analyses (including residual analyses) for each of the endogenous constructs (e.g., depression, IL-6, allostatic load). Joint normality was assessed. Structural equation modeling was then conducted to examine the mediating role of depressive symptoms as well as the moderating role of resilience comparing relationships between ever and never smokers. Age and sex were included as covariates for IL-6, CRP, and allostatic load. Estimation for the two-group model used maximum likelihood with missing values. No auxiliary variables were included, as missingness in the data was due to administration of different modules at different times independent of specific participant characteristics and were thus assumed to be missing completely at random. Indices used to assess model fit were chi-squared, the Root Mean Square Error of Approximation (RMSEA), and the Comparative Fit Index (CFI). Post SEM, residuals were inspected. Data were cleaned and descriptive, univariate, bivariate, and multivariable analyses were conducted using SAS 9.4. Structural equation modeling analyses were conducting using Stata 14. Based on results from the bivariate analyses, age and sex were included as covariates in the structural equation model.

RESULTS

Participant Characteristics

Ever smokers and never smokers differed across all sociodemographic dimensions, with ever smokers being older, more likely to be male, less educated, lower income earners (p’s<.001), more likely to be unemployed (p=.02), and more likely to receive disability (p=.04; Table 1). As the literature would suggest, ever smokers also reported experiencing more childhood and adulthood trauma (p’s<.001) and depressive symptoms (p=.01).

Table 1.

Participant characteristics and bivariate analyses examining differences between ever smokers and never smokers

Total Ever smoker Never smoker
M/N SD/% M/N SD/% M/N SD/% p
Sample size 852 100 608 71.36 244 28.64
Sociodemographics
Age 44.32 11.62 44.32 11.62 38.14 13.39 <.0001
Gender <.0001
  Male 302 35.53 246 40.53 56 23.05
  Female 548 64.47 361 59.47 187 76.95
Education <.0001
  Less than 12th grade 207 24.64 172 28.67 35 14.58
  12th grade or high school graduate 294 35.00 193 32.17 101 42.08
  GED 54 6.43 45 7.50 9 3.75
  Some college/tech school 186 22.14 124 20.67 62 25.83
  Tech school graduate 32 3.81 24 4.00 8 3.33
  College graduate 57 6.79 34 5.67 23 9.58
  Graduate degree 10 1.19 8 1.33 2 0.83
Monthly household income <.0001
  Less than $250 274 33.29 216 36.61 58 24.89
  $250–$499 87 10.57 62 10.51 25 10.73
  $500–$999 235 28.55 163 27.63 72 30.90
  $1000–$1999 163 19.81 108 18.31 55 23.61
  $2000 or more 64 7.78 41 6.95 23 9.87
Employment status (no reported) 668 79.43 490 81.53 178 74.17 0.02
Received disability (yes reported) 210 25.06 162 27.00 48 20.17 0.04
Primary Predictors
Childhood Trauma Questionnaire (CTQ) 43.62 18.26 45.20 19.32 39.72 14.65 <.0001
Traumatic Events Inventory (TEI) 3.59 2.51 3.95 2.55 2.64 2.14 <.0001
Connor-Davidson Resilience Scale (CDR) 30.88 8.32 30.87 8.15 30.90 8.78 .98
Beck Depression Inventory (BDI) 15.93 12.54 16.69 12.65 13.97 12.06 .01
Outcomes
Interleukin-6 (IL-6) 1.35 1.42 1.34 1.32 1.41 1.73 .73
C-Reactive Protein (CRP) 5.91 8.77 5.70 8.44 6.41 9.52 .47
Allostatic Load (AL) 2.08 1.34 2.04 1.36 2.18 1.28 .21

M: mean; N: sample size; SD: standard deviation

Structural Equation Model Results

The final structural equation model presented had good model fit: Χ2(30)=46.501, p=.03 overall, Χ2(15)=8.156, p=.92 for ever smokers, Χ2(15)=38.345, p=.001 for never smokers, RMSEA = 0.036, CFI = 0.950. The overall coefficient of determinant (CD) was 0.532, with CD=0.426 and 0.683 for ever and never smokers, respectively.

Table 2 and Figure 2 display the results of the structural equation models examining the impact of childhood and adulthood trauma (per the CTQ and TEI, respectively), resilience (per the CD-RISC), and depressive symptoms (per the BDI) on biomarkers of health risk (i.e., IL-6, CRP, and allostatic load) among ever and never smokers, respectively. In ever smokers, childhood trauma was positively associated with depressive symptoms (p<.001); resilience was negatively associated with depressive symptoms (p=.01). Depressive symptoms were positively associated with IL-6 (p=.03), which was positively associated with allostatic load (p=.01). Adulthood trauma was positively associated with CRP levels (p=.03). Older age was also associated with higher IL-6, and being female was associated with higher allostatic load.

Table 2.

Equation estimates for structural equation models for ever smokers and never smokers, respectively, and comparisons of coefficients across groups

Ever smokers Never smokers


Unstand.
Coefficient
SE z p 95% CI Stand.
Coefficient
Unstand.
Coefficient
SE z p 95% CI Stand.
Coefficient
p¥
CTQ→BDI 0.17 0.03 5.66 <.001 0.11 0.23 0.35 0.21 0.06 3.48 <.001 0.09 0.33 0.40 .55
TEI→BDI 0.33 0.22 1.49 .14 −0.10 0.77 0.15 1.05 0.42 2.50 .01 0.23 1.87 0.33 .13
CDR→BDI −0.44 0.18 −2.46 .01 −0.79 −0.09 −0.06 0.22 0.35 0.62 .53 −0.47 0.92 0.67 .10
CTQ*CDR→BDI 0.06 0.41 0.15 .88 −0.74 0.87 0.33 −2.35 1.00 −2.35 .02 −4.30 −0.39 −0.12 .03
TEI*CDR→BDI −5.96 3.68 −1.62 .11 −13.18 1.25 0.04 8.43 7.55 1.12 .26 −6.38 23.23 0.45 .09
BDI→CRP −0.10 0.05 −1.91 .06 −0.20 0.00 0.00 −0.08 0.08 −0.97 .33 −0.23 0.08 0.10 .82
TEI→CRP 0.44 0.21 2.12 .03 0.03 0.85 0.26 −2.01 0.45 −4.51 <.001 −2.88 −1.13 −0.26 <.001
CDR→CRP −0.05 0.14 −0.38 .71 −0.33 0.23 0.17 −0.99 0.15 −6.64 <.001 −1.29 −0.70 0.40 .07
TEI*CDR→CRP −1.54 2.92 −0.53 .60 −7.25 4.18 0.22 35.13 6.40 5.49 <.001 22.60 47.67 −0.64 <.001
Age→CRP 0.04 0.04 0.94 .35 −0.04 0.12 0.21 0.17 0.06 2.86 <.001 0.05 0.29 1.13 <.001
Female→CRP 0.77 1.10 0.69 .49 −1.40 2.93 0.17 3.68 1.83 2.01 .04 0.09 7.27 0.31 .17
BDI→IL-6 0.01 0.01 2.16 .03 0.00 0.03 0.27 −0.01 0.01 −0.60 .55 −0.04 0.02 0.14 .15
Age→IL-6 0.02 0.01 2.35 .02 0.00 0.03 0.25 0.04 0.02 2.36 .02 0.01 0.07 0.50 .21
Female→IL-6 0.21 0.16 1.31 .19 −0.10 0.52 0.19 −0.04 0.48 −0.08 .94 −0.98 0.91 0.22 .63
BDI→Allostatic load −0.01 0.00 −1.59 .11 −0.02 0.00 0.02 0.00 0.01 0.37 .71 −0.01 0.02 0.18 .25
CRP→Allostatic load 0.02 0.01 1.62 .11 0.00 0.04 0.22 0.04 0.01 3.05 <.001 0.01 0.06 0.44 .20
IL-6→Allostatic load 0.16 0.06 2.68 .01 0.04 0.28 0.27 0.09 0.09 1.06 .29 −0.08 0.26 0.36 .51
Age→Allostatic load 0.00 0.01 0.89 .37 −0.01 0.02 0.13 0.01 0.01 0.85 .40 −0.01 0.02 0.23 .85
Female→Allostatic load 0.55 0.12 4.48 <.001 0.31 0.79 0.28 0.22 0.23 0.94 .35 −0.23 0.67 0.22 .20

Equation-level goodness of fit

r-squared mc mc2 r-squared mc mc2
BDI 0.366 0.605 0.366 0.312 0.559 0.312
CRP 0.035 0.188 0.035 0.497 0.705 0.497
IL-6 0.042 0.205 0.042 0.083 0.288 0.083
Allostatic load 0.082 0.286 0.082 0.110 0.331 0.110
Overall 0.426 0.683
¥

Comparing coefficients across groups.

mc: correlation between the dependent variable and its prediction

mc2: Bentler Raykov squared multiple correlation coefficient

Figure 2.

Figure 2

Structural equation models examining the impact of trauma, resilience, and depressive symptoms on biological outcomes among ever smokers and never smokers, respectively

Note: Solid black lines indicate significant associations, whereas gray lines indicate insignificant associations.

In never smokers, childhood and adulthood trauma were positively associated with depressive symptoms (p<.001, p=.01). Adulthood trauma was also associated with higher CRP levels (p<.001), which was positively associated with allostatic load (p<.001). Never smokers with higher resilience showed a negative association between childhood trauma and depressive symptoms, whereas those with lower resilience showed a positive association between childhood trauma and depressive symptoms (see Figure 3). Resilience was negatively associated with CRP levels (p<.001). Older age and being female was also associated with higher CRP.

Figure 3.

Figure 3

Resilience moderating the relationship between childhood trauma and depression among never smokers

Note: No relationship among ever smokers (figure not shown).

In comparing coefficients across groups, differences were found regarding the interaction of childhood trauma and resilience on depressive symptoms (p=.03), adulthood trauma on CRP levels (p<.001), the interaction between adulthood trauma and resilience on CRP (p<.001), and age on CRP levels (p<.001).

DISCUSSION

The current study examined the role of resilience in moderating the impact of trauma exposure, depression, and resilience on biomarkers of “weathering” among Black ever versus never smokers. Examining these groups separately is critical, as our results and the prior literature (Agaku, King, Dube, et al., 2014; Agaku, King, Husten, et al., 2014) have demonstrated marked differences in the range of exposures across the exposome (e.g., sociodemographic, sociocontextual, psychological characteristics), with smokers experiencing more risk exposures across these dimensions (Al Mamun et al., 2007; APA, 1994; Breslau et al., 2003; Hapke et al., 2005). As anticipated, resilience served as a buffer between specific upstream risk factors (i.e., traumatic experiences) and downstream risk factors (i.e., depressive symptoms, health risk biomarkers). In addition, our hypothesis that resilience would differentially moderate the associations between traumatic experiences, depressive symptoms, and health risk biomarkers among ever versus never smokers was also supported.

First, these findings highlight the need for early intervention among Blacks experiencing childhood trauma. Our results show that, among ever smokers, childhood trauma – but not adulthood trauma – was associated with higher depressive symptoms. This finding points to biological embedding (Hertzman, 1999, 2012). Biological embedding suggests that long-term and stable differences in experience, under different nurturant conditions, lead to differences in learning and behavior over the life course. These differences can impact the weathering process and ultimately health outcomes (Essex et al., 2013). Our data indicates that childhood trauma leads to higher depressive symptoms. These higher depressive symptoms put one at risk for smoking initiation, which, in turn, can increase depressive symptoms (M. Windle & Windle, 2001) and, consequently, reduce the odds of successful cessation (Brody, Hamer, & Haaga, 2005; Catley, Ahluwalia, Resnicow, & Nazir, 2003; Chen, White, & Pandina, 2001; Covey, Glassman, & Stetner, 1990; Husky, Mazure, Paliwal, & McKee, 2008). This line of downstream consequences potentially prompted by early childhood environmental factors – specifically trauma – has long-term and potentially difficult-to-modify consequences, both in terms of depressive symptoms and health risk biomarkers, specifically IL-6 and allostatic load. However, resilience was associated with decreased depressive symptoms in ever smokers. This suggests the potential importance of promoting resilience as a construct among young people who have experienced traumatic events in order to prevent biological embedding that may directly lead to depression and indirectly to smoking initiation and progression (Brody et al., 2005; Catley et al., 2003; Chen et al., 2001; Covey et al., 1990; Husky et al., 2008).

Among never smokers, both childhood and adulthood trauma was associated with higher depressive symptoms. Whereas resilience was not significantly associated with depressive symptoms (as with ever smokers), it did serve as a moderator between childhood trauma and depressive symptoms in never smokers. Specifically, those with greater resilience demonstrated a negative association between levels of childhood trauma and depressive symptoms, whereas those with less resilience demonstrated a positive association between levels of childhood trauma and depressive symptoms. Interestingly, resilience was negatively associated with CRP levels among never smokers, indicating that resilience may particularly serve as a buffer for disease risk among Blacks who have never smoked.

The distinct roles of resilience among ever versus never smokers are difficult to interpret. One explanation is that relative to nonsmokers, smokers have a complement of interdependent vulnerabilities (e.g., less educated, lower income, unemployed) (Al Mamun et al., 2007; APA, 1994; Breslau et al., 2003; Hapke et al., 2005) along with their experiences of depression and trauma history. As such, the earlier childhood experiences of this group may have shaped their subsequent behaviors (e.g., substance use, academic performance). Those with higher levels of childhood trauma may have engaged in these damaging behaviors, which resulted in poorer quality of life. Yet, a higher resilience within this high-risk group may contribute to lower levels of depressive symptoms despite these vulnerabilities. On the other hand, individuals who never engaged in cigarette smoking, and who were less vulnerable in terms of sociodemographics and psychosocial experiences, were differentially impacted by childhood trauma. However, our cross-sectional data did not allow us to test this assumption. The impact of childhood traumatic events on depressive symptoms may have been mitigated by higher resilience.

Another finding that is interesting to note is that the two groups showed different associations between experiencing traumatic events in adulthood and CRP levels, such that experiencing greater adulthood traumatic events was associated with higher CRP levels in smokers while lower adulthood trauma was associated with higher CRP levels in never smokers. These findings warrant replication to ensure that these were not spurious findings and, if replicated, additional research to understand the differential mechanisms impacting the relationship between adulthood trauma and CRP levels in ever versus never smokers.

These findings collectively suggest that increasing resilience may buffer the impact of environmental risk factors. Further prospective study designs will be needed to confirm this. This research could take the form of randomized intervention trials that vary resilience-building activities in groups at high risk of accelerated weathering. Limited research has examined the utility of interventions targeting resilience in order to prevent or treat substance use, specifically smoking or nicotine dependence. While there is some controversy regarding whether resilience is a personality trait or a characteristic amenable to intervention (Yilmaz, Unal, Gencer, Aydemir, & Selcuk, 2015), some research indicates the promise of intervening on resilience. For example, some intervention research has shown that attempts to increase resilience in young adults have been effective in not only increasing resilience but also increasing coping skills and protective factors (e.g., positive affect, self-esteem) and decreasing symptoms of depression, stress, and negative affect (Steinhardt & Dolbier, 2008). Other research using a family-based resilience intervention has documented reductions in alcohol use among adolescents (Toumbourou, Gregg, Shortt, Hutchinson, & Slaviero, 2013). Indeed, there has been recent calls for social policies that promote resilience in order to decrease substance use and related costs (Luthar, Cicchetti, & Becker, 2000) and for interventions to increase resilience among youth that are multi-level, coordinated, continuous over time, and shown to be effective in order to meet the long-term needs of youth facing the cumulative disadvantages of family, community, school, and individual challenges (Ungar, Liebenberg, Landry, & Ikeda, 2012).

Limitations

Several study limitations are worth noting. First, the cross-sectional nature of this study and the use of retrospective self-reports prohibits us from making causal attributions and is vulnerable to bias. Prospective, longitudinal studies are required to examine the temporality of trauma in relation to smoking, depressive symptoms, and resulting health outcomes as well as the impact of resilience on these outcomes. Another limitation is that our sample was disproportionately female and low income, and we do not yet have the data to demonstrate if these findings would apply in other segments of the Black population. However, this weakness is counterbalanced by the public health importance of studying these variables in an often under-researched and under-served population with disproportionally high rates of trauma exposure as well as mental and physical health problems. Additionally, this is a study exclusively of Blacks. Thus, it is not possible to infer from the current analyses whether the documented associations would also be demonstrated within other racial or ethnic groups. Finally, it is important to note that several of our hypothesized associations were not significant. The strongest associations were found in the model representing never smokers, particularly the moderating effect of resilience on the relationship between childhood trauma experiences and depressive symptoms. The model representing ever smokers showed less robust associations, with the strongest associations being those between adulthood traumatic events and CRP levels as well as between resilience and depressive symptoms. As such, these analyses warrant replication in similar samples and in other more representative samples to establish which relationships are most robust, both in this population and in others.

Conclusions

The current findings point to the distinct role of resilience in buffering the impact of environmental stressors in Black ever versus never smokers. While resilience did not moderate the association between trauma and depressive symptoms in ever smokers, it was directly related to lower levels of depressive symptoms. In contrast, resilience was not directly related to depressive symptoms in never smokers but rather buffered the impact of traumatic experiences on depressive symptoms. In addition, resilience directly impacted specific health risk biomarkers in never smokers but only indirectly impacted specific health risk biomarkers in smokers via depressive symptoms. Ultimately, this study highlights the importance of resilience in preventing adverse health outcomes and provides a basis for understanding the mechanisms of change that might result from interventions targeting resilience in Black ever versus never smokers.

Acknowledgments

FUNDING

This work was primarily supported by the National Institute of Mental Health (MH071537, MH100122, MH102890, MH096764) and the National Institute of Child Health and Human Development (HD071982). Support also included Emory and Grady Memorial Hospital General Clinical Research Center, NIH National Centers for Research Resources (M01 RR00039), the Burroughs Welcome Fund, and Emory University’s Winship Cancer Institute (co-PIs: McBride, Berg). APW is supported by VA grant IK2CX000601.

References

  1. Agaku IT, King BA, Dube SR Centers for Disease, C., & Prevention. Current cigarette smoking among adults - United States, 2005–2012. MMWR Morbidity and Mortality Weekly Report. 2014;63(2):29–34. [PMC free article] [PubMed] [Google Scholar]
  2. Agaku IT, King BA, Husten CG, Bunnell R, Ambrose BK, Hu SS Prevention. Tobacco product use among adults--United States, 2012–2013. MMWR Morbidity and Mortality Weekly Report. 2014;63(25):542–547. [PMC free article] [PubMed] [Google Scholar]
  3. Al Mamun A, Alati R, O'Callaghan M, Hayatbakhsh MR, O'Callaghan FV, Najman JM, Bor W. Does childhood sexual abuse have an effect on young adults' nicotine disorder (dependence or withdrawal)? Evidence from a birth cohort study. Addiction. 2007;102(4):647–654. doi: 10.1111/j.1360-0443.2006.01732.x. [DOI] [PubMed] [Google Scholar]
  4. Alexander LA, Trinidad DR, Sakuma KL, Pokhrel P, Herzog TA, Clanton MS, Fagan P. Why We Must Continue to Investigate Menthol's Role in the African American Smoking Paradox. Nicotine and Tobacco Research. 2016;18(Suppl 1):S91–101. doi: 10.1093/ntr/ntv209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. American Cancer Society. Cancer Facts and Figures 2011. Atlanta, GA: 2011. Retrieved from. [Google Scholar]
  6. American Psychological Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: 1994. Retrieved from. [Google Scholar]
  7. Barboza Solis C, Kelly-Irving M, Fantin R, Darnaudery M, Torrisani J, Lang T, Delpierre C. Adverse childhood experiences and physiological wear-and-tear in midlife: Findings from the 1958 British birth cohort. Proceedings of the National Academy of Science USA. 2015;112(7):E738–746. doi: 10.1073/pnas.1417325112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry. 1961;4:561–571. doi: 10.1001/archpsyc.1961.01710120031004. [DOI] [PubMed] [Google Scholar]
  9. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22(10):1668–1673. doi: 10.1161/01.atv.0000029781.31325.66. [DOI] [PubMed] [Google Scholar]
  10. Bernstein D, Fink L. Childhood Trauma Questionnaire Manual. San Antonio, TX: Psychological Corp.; 1998. [Google Scholar]
  11. Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Zule W. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse and Neglect. 2003;27(2):169–190. doi: 10.1016/s0145-2134(02)00541-0. [DOI] [PubMed] [Google Scholar]
  12. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, Ressler KJ. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA. 2008;299(11):1291–1305. doi: 10.1001/jama.299.11.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bradley RG, Binder EB, Epstein MP, Tang Y, Nair HP, Liu W, Ressler KJ. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Archives of General Psychiatry. 2008;65(2):190–200. doi: 10.1001/archgenpsychiatry.2007.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Breslau N, Davis GC, Andreski P. Risk factors for PTSD-related traumatic events: a prospective analysis. Am J Psychiatry. 1995;152(4):529–535. doi: 10.1176/ajp.152.4.529. [DOI] [PubMed] [Google Scholar]
  15. Breslau N, Davis GC, Schultz LR. Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma. Archives of General Psychiatry. 2003;60(3):289–294. doi: 10.1001/archpsyc.60.3.289. [DOI] [PubMed] [Google Scholar]
  16. Breslau N, Kessler RC, Chilcoat HD, Schultz LR, Davis GC, Andreski P. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Archives of General Psychiatry. 1998;55(7):626–632. doi: 10.1001/archpsyc.55.7.626. [DOI] [PubMed] [Google Scholar]
  17. Brody CL, Hamer DH, Haaga DA. Depression vulnerability, cigarette smoking, and the serotonin transporter gene. Addictive Behaviors. 2005;30(3):557–566. doi: 10.1016/j.addbeh.2004.08.005. doi:S0306-4603(04)00283-710.1016/j.addbeh.2004.08.005. [DOI] [PubMed] [Google Scholar]
  18. Campbell-Sills L, Stein MB. Psychometric analysis and refinement of the Connor-davidson Resilience Scale (CD-RISC): Validation of a 10-item measure of resilience. Journal of Trauma and Stress. 2007;20(6):1019–1028. doi: 10.1002/jts.20271. [DOI] [PubMed] [Google Scholar]
  19. Casiano H, Mota N, Afifi TO, Enns MW, Sareen J. Childhood maltreatment and threats with weapons. Journal of Nervous and Mental Disorders. 2009;197(11):856–861. doi: 10.1097/NMD.0b013e3181be9c55. [DOI] [PubMed] [Google Scholar]
  20. Catley D, Ahluwalia JS, Resnicow K, Nazir N. Depressive symptoms and smoking cessation among inner-city African Americans using the nicotine patch. Nicotine and Tobacco Research. 2003;5(1):61–68. doi:CDLTHMGVLB7C9AYV [pii] [PubMed] [Google Scholar]
  21. Centers for Disease Control and Prevention. Tobacco use among U.S. racial/ethnic minority groups, African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, Hispanics: A report of the Surgeon General (Executive Summary) MMWR. 1998;47(RR-18):1–16. [PubMed] [Google Scholar]
  22. Chaturvedi AK, Caporaso NE, Katki HA, Wong HL, Chatterjee N, Pine SR, Engels EA. C-reactive protein and risk of lung cancer. Journal of Clinical Oncology. 2010;28(16):2719–2726. doi: 10.1200/JCO.2009.27.0454. doi:JCO.2009.27.045410.1200/JCO.2009.27.0454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Chen PH, White HR, Pandina RJ. Predictors of smoking cessation from adolescence into young adulthood. Addictive Behaviors. 2001;26(4):517–529. doi: 10.1016/s0306-4603(00)00142-8. [DOI] [PubMed] [Google Scholar]
  24. Cicchetti D, Rogosch FA. The role of self-organization in the promotion of resilience in maltreated children. Developmental Psychopathology. 1997;9(4):797–815. doi: 10.1017/s0954579497001442. [DOI] [PubMed] [Google Scholar]
  25. Collishaw S, Pickles A, Messer J, Rutter M, Shearer C, Maughan B. Resilience to adult psychopathology following childhood maltreatment: evidence from a community sample. Child Abuse and Neglect. 2007;31(3):211–229. doi: 10.1016/j.chiabu.2007.02.004. [DOI] [PubMed] [Google Scholar]
  26. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC) Depression and Anxiety. 2003;18(2):76–82. doi: 10.1002/da.10113. [DOI] [PubMed] [Google Scholar]
  27. Covey LS, Glassman AH, Stetner F. Depression and depressive symptoms in smoking cessation. Comprehensive Psychiatry. 1990;31(4):350–354. doi: 10.1016/0010-440x(90)90042-q. doi:0010-440X(90)90042-Q [pii] [DOI] [PubMed] [Google Scholar]
  28. Doamekpor LA, Dinwiddie GY. Allostatic Load in Foreign-Born and US-Born Blacks: Evidence From the 2001–2010 National Health and Nutrition Examination Survey. American Journal of Public Health. 2015;105(3):591–597. doi: 10.2105/Ajph.2014.302285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Enns MW, Cox BJ, Afifi TO, De Graaf R, Ten Have M, Sareen J. Childhood adversities and risk for suicidal ideation and attempts: a longitudinal population-based study. Psychological Medicine. 2006;36(12):1769–1778. doi: 10.1017/S0033291706008646. [DOI] [PubMed] [Google Scholar]
  30. Essex MJ, Boyce WT, Hertzman C, Lam LL, Armstrong JM, Neumann SMA, Kobor MS. Epigenetic Vestiges of Early Developmental Adversity: Childhood Stress Exposure and DNA Methylation in Adolescence. Child Development. 2013;84(1):58–75. doi: 10.1111/j.1467-8624.2011.01641.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ferguson-Smith AC, Chen YF, Newman MS, May LT, Sehgal PB, Ruddle FH. Regional localization of the interferon-beta 2/B-cell stimulatory factor 2/hepatocyte stimulating factor gene to human chromosome 7p15-p21. Genomics. 1988;2(3):203–208. doi: 10.1016/0888-7543(88)90003-1. doi:0888-7543(88)90003-1 [pii] [DOI] [PubMed] [Google Scholar]
  32. Fergusson DM, Horwood LJ, Lynskey MT. Childhood sexual abuse and psychiatric disorder in young adulthood: II. Psychiatric outcomes of childhood sexual abuse. Journal of the American Academy of Child and Adolescent Psychiatry. 1996;35(10):1365–1374. doi: 10.1097/00004583-199610000-00024. [DOI] [PubMed] [Google Scholar]
  33. Festa A, D'Agostino R, Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation. 2000;102(1):42–47. doi: 10.1161/01.cir.102.1.42. [DOI] [PubMed] [Google Scholar]
  34. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, Sattar N. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2002;51(5):1596–1600. doi: 10.2337/diabetes.51.5.1596. [DOI] [PubMed] [Google Scholar]
  35. Geronimus AT, Bound J, Waidmann TA, Hillemeier MM, Burns PB. Excess mortality among blacks and whites in the United States. New England Journal of Medicine. 1996;335(21):1552–1558. doi: 10.1056/NEJM199611213352102. [DOI] [PubMed] [Google Scholar]
  36. Geronimus AT, Hicken M, Keene D, Bound J. "Weathering" and age patterns of allostatic load scores among blacks and whites in the United States. American Journal of Public Health. 2006;96(5):826–833. doi: 10.2105/AJPH.2004.060749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Gilbert R, Widom CS, Browne K, Fergusson D, Webb E, Janson S. Burden and consequences of child maltreatment in high-income countries. Lancet. 2009;373(9657):68–81. doi: 10.1016/S0140-6736(08)61706-7. [DOI] [PubMed] [Google Scholar]
  38. Gillespie CF, Bradley B, Mercer K, Smith AK, Conneely K, Gapen M, Ressler KJ. Trauma exposure and stress-related disorders in inner city primary care patients. General Hospital Psychiatry. 2009;31(6):505–514. doi: 10.1016/j.genhosppsych.2009.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Goldstein AL, Faulkner B, Wekerle C. The relationship among internal resilience, smoking, alcohol use, and depression symptoms in emerging adults transitioning out of child welfare. Child Abuse and Negl. 2013;37(1):22–32. doi: 10.1016/j.chiabu.2012.08.007. [DOI] [PubMed] [Google Scholar]
  40. Gonzalez VBA, Sierra MTC, Martinez BA, Martinez-Molina A, Ponce FP. An in-depth psychometric analysis of the Connor-Davidson Resilience Scale: calibration with Rasch-Andrich model. Health and Quality of Life Outcomes. 2015;13 doi: 10.1186/s12955-015-0345-y. doi:ARTN 15410.1186/s12955-015-0345-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Green BL, Grace MD, Lindy JD, Leonard AC. Race differences in response to combat stress. Journal of Trauma and Stress. 1990;3:379–393. [Google Scholar]
  42. Hapke U, Schumann A, Rumpf HJ, John U, Konerding U, Meyer C. Association of smoking and nicotine dependence with trauma and posttraumatic stress disorder in a general population sample. Journal of Nervous and Mental Disorders. 2005;193(12):843–846. doi: 10.1097/01.nmd.0000188964.83476.e0. [DOI] [PubMed] [Google Scholar]
  43. Hertzman C. The biological embedding of early experience and its effects on health in adulthood. Annals of the New York Academy of Scienc. 1999;896:85–95. doi: 10.1111/j.1749-6632.1999.tb08107.x. [DOI] [PubMed] [Google Scholar]
  44. Hertzman C. Putting the concept of biological embedding in historical perspective. Proceedings of the National Academy of Science USA. 2012;109(Suppl 2):17160–17167. doi: 10.1073/pnas.1202203109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Holford TR, Levy DT, Meza R. Comparison of Smoking History Patterns Among African American and White Cohorts in the United States Born 1890 to 1990. Nicotine and Tobacco Research. 2016;18(Suppl 1):S16–29. doi: 10.1093/ntr/ntv274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Hovdestad W, Campeau A, Potter D, Tonmyr L. A systematic review of childhood maltreatment assessments in population-representative surveys since 1990. PLoS One. 2015;10(5):e0123366. doi: 10.1371/journal.pone.0123366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Husky MM, Mazure CM, Paliwal P, McKee SA. Gender differences in the comorbidity of smoking behavior and major depression. Drug and Alcohol Dependence. 2008;93(1–2):176–179. doi: 10.1016/j.drugalcdep.2007.07.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Jaffee S, Gallop R. Social, emotional, and academic competence among children who have had contact with child protective services: Prevalence and stability estimates. Journal of the American Academy of Child and Adolescent Psychiatry. 2007;46:757–765. doi: 10.1097/chi.0b013e318040b247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Juarez P. Sequencing the public health genome. Journal of Health Care for the Poor and Underserved. 2013;24(1 Suppl):114–120. doi: 10.1353/hpu.2013.0035. [DOI] [PubMed] [Google Scholar]
  50. Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman TE. Allostatic load as a predictor of functional decline MacArthur studies of successful aging. Journal of Clinical Epidemiology. 2002;55(7):696–710. doi: 10.1016/s0895-4356(02)00399-2. doi:Pii S0895-4356(02)00399-2. [DOI] [PubMed] [Google Scholar]
  51. Kellogg SH, McHugh PF, Bell K, Schluger JH, Schluger RP, LaForge KS, Kreek MJ. The Kreek-McHugh-Schluger-Kellogg scale: a new, rapid method for quantifying substance abuse and its possible applications. Drug and Alcohol Dependence. 2003;69(2):137–150. doi: 10.1016/s0376-8716(02)00308-3. [DOI] [PubMed] [Google Scholar]
  52. Kessler RC, Davis CG, Kendler KS. Childhood adversity and adult psychiatric disorder in the US National Comorbidity Survey. Psychological Medicine. 1997;27(5):1101–1119. doi: 10.1017/s0033291797005588. [DOI] [PubMed] [Google Scholar]
  53. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Pepys MB. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999;99(2):237–242. doi: 10.1161/01.cir.99.2.237. [DOI] [PubMed] [Google Scholar]
  54. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. New England Journal of Medicine. 2000;343(16):1139–1147. doi: 10.1056/NEJM200010193431602. [DOI] [PubMed] [Google Scholar]
  55. Luthar SS, Cicchetti D, Becker B. The construct of resilience: a critical evaluation and guidelines for future work. Child Development. 2000;71(3):543–562. doi: 10.1111/1467-8624.00164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. MacMillan HL, Fleming JE, Streiner DL, Lin E, Boyle MH, Jamieson E, Beardslee WR. Childhood abuse and lifetime psychopathology in a community sample. American J Psychiatry. 2001;158(11):1878–1883. doi: 10.1176/appi.ajp.158.11.1878. [DOI] [PubMed] [Google Scholar]
  57. Masten AS. Ordinary magic. Resilience processes in development. Am Psychol. 2001;56(3):227–238. doi: 10.1037//0003-066x.56.3.227. [DOI] [PubMed] [Google Scholar]
  58. Mauss D, Li J, Schmidt B, Angerer P, Jarczok MN. Measuring allostatic load in the workforce: a systematic review. Industrial Health. 2015;53(1):5–20. doi: 10.2486/indhealth.2014-0122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998;840:33–44. doi: 10.1111/j.1749-6632.1998.tb09546.x. [DOI] [PubMed] [Google Scholar]
  60. McGloin JM, Widom CS. Resilience among abused and neglected children grown up. Dev Psychopathol. 2001;13(4):1021–1038. doi: 10.1017/s095457940100414x. [DOI] [PubMed] [Google Scholar]
  61. Miller GW, Jones DP. The Nature of Nurture: Refining the Definition of the Exposome. Toxicological Sciences. 2014;137(1):1-+. doi: 10.1093/toxsci/kft251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. O'Donnell ML, Creamer M, Pattison P. Posttraumatic stress disorder and depression following trauma: understanding comorbidity. Am J Psychiatry. 2004;161(8):1390–1396. doi: 10.1176/appi.ajp.161.8.1390. [DOI] [PubMed] [Google Scholar]
  63. Ohsawa M, Okayama A, Nakamura M, Onoda T, Kato K, Itai K, Hiramori K. CRP levels are elevated in smokers but unrelated to the number of cigarettes and are decreased by long-term smoking cessation in male smokers. Preventive Medicine. 2005;41(2):651–656. doi: 10.1016/j.ypmed.2005.02.002. [DOI] [PubMed] [Google Scholar]
  64. Ou SR, Reynolds AJ. Childhood Predictors of Young Adult Male Crime. Child and Youth Service Review. 2010;32(8):1097–1107. doi: 10.1016/j.childyouth.2010.02.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, 3rd, Criqui M, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511. doi: 10.1161/01.cir.0000052939.59093.45. [DOI] [PubMed] [Google Scholar]
  66. Ridker PM. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? Circulation. 1998;97(17):1671–1674. doi: 10.1161/01.cir.97.17.1671. [DOI] [PubMed] [Google Scholar]
  67. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391–397. doi: 10.1161/01.cir.0000055014.62083.05. [DOI] [PubMed] [Google Scholar]
  68. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97(5):425–428. doi: 10.1161/01.cir.97.5.425. [DOI] [PubMed] [Google Scholar]
  69. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine. 2002;347(20):1557–1565. doi: 10.1056/NEJMoa021993. [DOI] [PubMed] [Google Scholar]
  70. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, Wilson PW. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32(11):2575–2579. doi: 10.1161/hs1101.098151. [DOI] [PubMed] [Google Scholar]
  71. Schwartz AC, Bradley RL, Sexton M, Sherry A, Ressler KJ. Posttraumatic stress disorder among African Americans in an inner city mental health clinic. Psychiatric Services. 2005;56(2):212–215. doi: 10.1176/appi.ps.56.2.212. [DOI] [PubMed] [Google Scholar]
  72. Scott KM, Smith DR, Ellis PM. Prospectively ascertained child maltreatment and its association with DSM-IV mental disorders in young adults. Archives of General Psychiatry. 2010;67(7):712–719. doi: 10.1001/archgenpsychiatry.2010.71. [DOI] [PubMed] [Google Scholar]
  73. Seeman TE, Crimmins E, Huang MH, Singer B, Bucur A, Gruenewald T, Reuben DB. Cumulative biological risk and socio-economic differences in mortality: MacArthur Studies of Successful Aging. Social Science & Medicine. 2004;58(10):1985–1997. doi: 10.1016/S0277-9536(03)00402-7. [DOI] [PubMed] [Google Scholar]
  74. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(8):4770–4775. doi: 10.1073/pnas.081072698. doi: [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Seeman TE, Singer B, Ryff C, Levy-Storms L. Psychosocial factors and the development of allostatic load. Psychosomatic Medicine. 2002;64:395–406. doi: 10.1097/00006842-200205000-00004. [DOI] [PubMed] [Google Scholar]
  76. Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS. Price of adaptation - Allostatic load and its health consequences - MacArthur studies of successful aging. Archives of Internal Medicine. 1997;157(19):2259–2268. [PubMed] [Google Scholar]
  77. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and the risk of developing hypertension. JAMA. 2003;290(22):2945–2951. doi: 10.1001/jama.290.22.2945. [DOI] [PubMed] [Google Scholar]
  78. Simpson TL, Miller WR. Concomitance between childhood sexual and physical abuse and substance use problems. A review. Clinical Psychology Review. 2002;22(1):27–77. doi: 10.1016/s0272-7358(00)00088-x. [DOI] [PubMed] [Google Scholar]
  79. Steinhardt M, Dolbier C. Evaluation of a resilience intervention to enhance coping strategies and protective factors and decrease symptomatology. Journal of American College Health. 2008;56(4):445–453. doi: 10.3200/JACH.56.44.445-454. [DOI] [PubMed] [Google Scholar]
  80. Steptoe A, Hackett RA, Lazzarino AI, Bostock S, La Marca R, Carvalho LA, Hamer M. Disruption of multisystem responses to stress in type 2 diabetes: investigating the dynamics of allostatic load. Proceedings from the National Academy of Science USA. 2014;111(44):15693–15698. doi: 10.1073/pnas.1410401111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Toumbourou JW, Gregg ME, Shortt AL, Hutchinson DM, Slaviero TM. Reduction of adolescent alcohol use through family-school intervention: a randomized trial. Journal of Adolescent Health. 2013;53(6):778–784. doi: 10.1016/j.jadohealth.2013.07.005. [DOI] [PubMed] [Google Scholar]
  82. Trichopoulos D, Psaltopoulou T, Orfanos P, Trichopoulou A, Boffetta P. Plasma C-reactive protein and risk of cancer: a prospective study from Greece. Cancer Epidemiology, Biomarkers and Prevention. 2006;15(2):381–384. doi: 10.1158/1055-9965.EPI-05-0626. doi:15/2/38110.1158/1055-9965.EPI-05-0626. [DOI] [PubMed] [Google Scholar]
  83. Ungar M, Liebenberg L, Landry N, Ikeda J. Caregivers, young people with complex needs, and multiple service providers: a study of triangulated relationships. Family Process. 2012;51(2):193–206. doi: 10.1111/j.1545-5300.2012.01395.x. [DOI] [PubMed] [Google Scholar]
  84. Upchurch DM, Stein J, Greendale GA, Chyu L, Tseng CH, Huang MH, Seeman T. A Longitudinal Investigation of Race, Socioeconomic Status, and Psychosocial Mediators of Allostatic Load in Midlife Women: Findings From the Study of Women's Health Across the Nation. Psychosomatic Medicine. 2015;77(4):402–412. doi: 10.1097/PSY.0000000000000175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, Harris TB. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation. 2001;103(7):947–953. doi: 10.1161/01.cir.103.7.947. [DOI] [PubMed] [Google Scholar]
  86. Wild CP. The exposome: from concept to utility. International Journal of Epidemiology. 2012;41(1):24–32. doi: 10.1093/ije/dyr236. [DOI] [PubMed] [Google Scholar]
  87. Windle G, Bennett KM, Noyes J. A methodological review of resilience measurement scales. Health and Quality of Life Outcomes. 2011;9 doi: 10.1186/1477-7525-9-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Windle M, Windle RC. Depressive symptoms and cigarette smoking among middle adolescents: prospective associations and intrapersonal and interpersonal influences. Journal of Consulting and Clinical Psychology. 2001;69(2):215–226. [PubMed] [Google Scholar]
  89. Wolfe DA, Scott K, Wekerle C, Pittman AL. Child maltreatment: risk of adjustment problems and dating violence in adolescence. Journal of the American Acadacmy of Child and Adolescent Psychiatry. 2001;40(3):282–289. doi: 10.1097/00004583-200103000-00007. [DOI] [PubMed] [Google Scholar]
  90. Yilmaz ED, Unal O, Gencer GG, Aydemir O, Selcuk Z. Static/Unchangeable and Dynamic/Changeable Nature of Personality According to the Nine Types Temperament Model: A Proposal. International Journal of Emergency Mental Health and Human Resilience. 2015;17(1):298–303. [Google Scholar]
  91. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19(4):972–978. doi: 10.1161/01.atv.19.4.972. [DOI] [PubMed] [Google Scholar]

RESOURCES